Pharmacological MPH
Methylphenidate
Methylphenidate is an FDA-approved stimulant medication widely used as a first-line treatment for ADHD.
It functions by inhibiting the reuptake of dopamine and norepinephrine to regulate inattention and impulsivity. Like other stimulants, it is a controlled substance requiring close monitoring due to abuse potential and side effects (e.g., appetite suppression, and sleep disruption).
Examples Ritalin, Concerta, Medikinet, or Equasym
References 2
- Faraone SV. The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neurosci Biobehav Rev. 2018;87:255-270. doi:10.1016/j.neubiorev.2018.02.001
- Cortese S. Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder. N Engl J Med. 2020;383(11):1050-1056. doi:10.1056/NEJMra1917069
Number of meta-analyses
- Preschool (0-5): no meta-analysis
- School-age (6-12): 32 meta-analyses
- Adolescents (13-17): no meta-analysis
- Adults (18+): no meta-analysis
One meta-analysis per outcome and age group, shown in the Intervention explorer.
See its evidence